Company Updates

In 2015 Métier Medical widened its footprint as an advocate for safe injection policy and the use of safety engineered injection devices with the election of the Company’s US based President to the World Health Organisation’s committee to assist in the implementation of it’s global Safe Injection policy announced in February 2015. Supporting the Company’s […]

We have completed a number of exciting transactions this year including the sale of 541 St Kilda Road and the redevelopment of The Marketplace, Auburn delivered solid returns for our investors. We successfully launched the APN Coburg North Retail Fund which is in a good position to deliver sustainable income yield and potential for capital […]

Avenir Capital continued to generate attractive long-term returns for our investors via our strategy of investing in fundamental, value oriented and special situation investments in global equity markets.  In September 2015, Avenir was selected by the ASX-listed Future Generation Global Investment Company as one of their panel of international fund managers. Our selection is testament to our private […]

Highlights include: Successful private equity capital raising:  MBD sought AUD 15M to fund commercial expansion in Australia for the companies high value pigment project and expansion of the companies bioremediation projects in North Queensland.  These funds have been raised over the last 6 months with the final 7M confirmed under a term sheet where the […]

In 2015, Analytica (ASX:ALT) achieved a critical regulatory milestone receiving 510(k) clearance with the US FDA for the PeriCoach, which along with Australian and European approval, allows the company to sell the product globally. Analytica also undertook a rights issue which raised $2.9 million. The company increased its US sales and marketing efforts with a […]

MediKane’s flagship product was featured on 7 National News in September which increased sales dramatically and assisted acquiring funding of $630,000. This increased demand required the appointment of a sales manager and two additional directors including a CFO and Marketing. Multiple sales contracts were finalised with pharmaceutical companies, Diabetes Australia, three Australian distributors plus China […]

Universal Biosensors has seen its share price more than double over the year, up from 17.6c on January 5 to 44.5c on December 14 – an increase of 159%. The company’s financial performance has also been strong, with total revenues in the first half up 160% on the prior corresponding period and quarterly service fees […]

Kube Systems featured in last week’s New York Times in a story on Kube’s “brand standard” relationship with Marriott Hotels. Kube solves the problem of mobile phone “dead battery anxiety” for customers of hospitality venues – and provides real returns for those venues. Kube is developing data analytics for venues and interactive possibilities for venue […]

16th December 2015 Folkestone is pleased to announce that it has established the Folkestone Wollert Development Fund which has entered into a 50-50 joint venture with ID_Land to develop a 48 hectare residential master planned community in Wollert (“Project”), in Melbourne’s rapidly growing Northern Growth Corridor. The Project is located within the Wollert Precinct Structure […]